Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Lactospey Kids is an oral probiotic and prebiotic formulation developed by SPEY specifically for pediatric use. It is designed to support and restore healthy intestinal microflora, promote digestion, and prevent or treat gastrointestinal disturbances such as acute or chronic diarrhea, antibiotic-associated diarrhea, and dysbiosis. Depending on the regional formulation, Lactospey Kids is supplied as oral sachets containing either a blend of lactic acid bacteria (including *Lactobacillus rhamnosus*, *Lactobacillus paracasei*, *Lactobacillus reuteri*, *Lactobacillus bulgaricus*, *Streptococcus thermophilus*, and *Bifidobacterium* species) or a combination of *Saccharomyces boulardii* and *Lactobacillus rhamnosus*, both enriched with the prebiotic inulin.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Lactospey Kids.